HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
POLR1D
RNA polymerase I and III subunit D
Chromosome 13 Β· 13q12.2
NCBI Gene: 51082Ensembl: ENSG00000186184.20HGNC: HGNC:20422UniProt: A0A087WTY1
84PubMed Papers
21Diseases
0Drugs
19Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
transcription by RNA polymerase IIIRNA polymerase I complexprotein bindingRNA polymerase III complexTreacher Collins syndrome 2Treacher-Collins syndromegenetic disorderneurodegenerative disease
✦AI Summary

POLR1D encodes a shared subunit of RNA polymerases I and III that plays dual roles in development and disease 1. As a core component of these polymerases, POLR1D is essential for synthesizing ribosomal RNA precursors and small non-coding RNAs including 5S rRNA, snRNAs, tRNAs, and miRNAs 2. The protein functions by heterodimerizing with POLR1C to initiate assembly of multisubunit RNA polymerase complexes 1. Pathogenic POLR1D mutations cause Treacher Collins syndrome (TCS), a craniofacial ribosomopathy characterized by microtia, midface hypoplasia, micrognathia, and hearing loss 3. Disease mechanisms involve impaired rRNA synthesis and nucleolar dysfunction that selectively sensitizes cranial neural crest cells to p53-mediated apoptosis 4. Missense mutations like G52E reduce heterodimerization with POLR1C and impair rRNA production 5. Beyond developmental disorders, POLR1D is frequently overexpressed in colorectal and lung cancers 6, 7, 8. High POLR1D expression correlates with poor prognosis and promotes cell proliferation through Wnt-Ξ²-catenin and PI3K-Akt pathway activation 6, 8. Notably, POLR1D localizes to the cytoplasm where it interacts with mTORC1 regulators RAGA and RAPTOR, suggesting an unexpected role in nutrient sensing beyond transcription 1.

Sources cited
1
POLR1D is a shared subunit of RNA polymerases I and III that forms a dimer with POLR1C to initiate polymerase assembly and regulates mTORC1 signaling through cytoplasmic interactions
PMID: 40222657
2
POLR1D variants cause RNA polymerase III-related disorders with developmental phenotypes affecting the CNS, eyes, connective tissues, and reproductive system
PMID: 40684265
3
POLR1D mutations cause Treacher Collins syndrome with features including microtia, conductive hearing loss, midface hypoplasia, and micrognathia
PMID: 34573374
4
POLR1D defects in Treacher Collins syndrome cause nucleolar dysfunction and rDNA damage leading to cell-type-selective p53-mediated apoptosis in cranial neural crest cells
PMID: 29364875
5
POLR1D missense mutations like G52E impair heterodimerization with POLR1C and reduce rRNA synthesis, affecting Drosophila development
PMID: 35656583
6
POLR1D is overexpressed in colorectal cancer and promotes cell proliferation through Wnt-Ξ²-catenin and p53 signaling with poor patient prognosis
PMID: 30582221
7
POLR1D overexpression correlates with advanced clinical stage, metastasis, and poor overall survival in colorectal cancer patients
PMID: 31722331
8
POLR1D silencing suppresses lung cancer cell proliferation and migration via inhibition of the PI3K-Akt pathway
PMID: 38844975
Disease Associationsβ“˜21
Treacher Collins syndrome 2Open Targets
0.75Strong
Treacher-Collins syndromeOpen Targets
0.68Moderate
genetic disorderOpen Targets
0.19Weak
neurodegenerative diseaseOpen Targets
0.15Weak
Hearing impairmentOpen Targets
0.12Weak
ovarian neoplasmOpen Targets
0.11Weak
colorectal carcinomaOpen Targets
0.08Suggestive
exostosisOpen Targets
0.06Suggestive
isolated asymptomatic elevation of creatine phosphokinaseOpen Targets
0.06Suggestive
pentosuriaOpen Targets
0.04Suggestive
trauma complicationOpen Targets
0.03Suggestive
oral squamous cell carcinomaOpen Targets
0.03Suggestive
lung cancerOpen Targets
0.02Suggestive
acquired thrombocytopeniaOpen Targets
0.02Suggestive
infectionOpen Targets
0.02Suggestive
colorectal cancerOpen Targets
0.02Suggestive
cancerOpen Targets
0.01Suggestive
neoplasmOpen Targets
0.01Suggestive
osteosarcomaOpen Targets
0.01Suggestive
visceral LeishmaniasisOpen Targets
0.01Suggestive
Treacher Collins syndrome 2UniProt
Pathogenic Variants19
NM_015972.4(POLR1D):c.60dup (p.Gly21fs)Likely pathogenic
Treacher Collins syndrome 2
β˜…β˜…β˜†β˜†2023β†’ Residue 21
NM_015972.4(POLR1D):c.99_144del (p.Gly34fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2026β†’ Residue 34
NM_015972.4(POLR1D):c.232_233del (p.Ser78fs)Pathogenic
Treacher Collins syndrome 2
β˜…β˜†β˜†β˜†2025β†’ Residue 78
NM_015972.4(POLR1D):c.31del (p.Ile11fs)Likely pathogenic
Treacher Collins syndrome 2
β˜…β˜†β˜†β˜†2025β†’ Residue 11
NM_015972.4(POLR1D):c.109dup (p.Arg37fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 37
NM_015972.4(POLR1D):c.227C>A (p.Ser76Ter)Likely pathogenic
Treacher Collins syndrome 2
β˜…β˜†β˜†β˜†2025β†’ Residue 76
NM_015972.4(POLR1D):c.259C>T (p.Arg87Ter)Likely pathogenic
Treacher Collins syndrome 2|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 87
NM_015972.4(POLR1D):c.139G>A (p.Glu47Lys)Likely pathogenic
Treacher Collins syndrome 2|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 47
NM_015972.4(POLR1D):c.265_268delinsTCTGAA (p.Thr89fs)Likely pathogenic
POLR1D-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 89
NM_015972.4(POLR1D):c.89_117del (p.Val30fs)Likely pathogenic
Treacher Collins syndrome 2
β˜…β˜†β˜†β˜†2022β†’ Residue 30
NM_015972.4(POLR1D):c.170dup (p.Tyr57Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 57
NM_015972.4(POLR1D):c.220dup (p.His74fs)Likely pathogenic
Treacher Collins syndrome 2
β˜…β˜†β˜†β˜†β†’ Residue 74
NM_015972.4(POLR1D):c.128dup (p.Leu44fs)Likely pathogenic
POLR1D-related disorder
β˜†β˜†β˜†β˜†2023β†’ Residue 44
NM_015972.4(POLR1D):c.163C>G (p.Leu55Val)Pathogenic
Treacher Collins syndrome 2|Treacher Collins syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 55
NM_015972.4(POLR1D):c.88_89dup (p.Gln31fs)Pathogenic
Treacher Collins syndrome 2
β˜†β˜†β˜†β˜†2011β†’ Residue 31
NM_015972.4(POLR1D):c.262_263dup (p.Thr89fs)Pathogenic
Treacher Collins syndrome 2
β˜†β˜†β˜†β˜†2011β†’ Residue 89
NM_015972.4(POLR1D):c.326_327del (p.His109fs)Pathogenic
Treacher Collins syndrome 2
β˜†β˜†β˜†β˜†2011β†’ Residue 109
NM_015972.4(POLR1D):c.152T>G (p.Leu51Arg)Pathogenic
Treacher Collins syndrome 2
β˜†β˜†β˜†β˜†2011β†’ Residue 51
NM_015972.4(POLR1D):c.261del (p.Gly88fs)Pathogenic
Treacher Collins syndrome 2
β˜†β˜†β˜†β˜†β†’ Residue 88
View on ClinVar β†—
Related Genes
TCOF1Protein interaction100%POLR2IProtein interaction100%TSR2Protein interaction100%TAF1BProtein interaction100%POLIProtein interaction100%POLR3GLProtein interaction100%
Tissue Expression6 tissues
Ovary
100%
Bone Marrow
97%
Lung
93%
Liver
81%
Brain
73%
Heart
66%
Gene Interaction Network
Click a node to explore
POLR1DTCOF1POLR2ITSR2TAF1BPOLIPOLR3GL
PROTEIN STRUCTURE
Preparing viewer…
PDB7OB9 Β· 2.70 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.63LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.90 [0.51–1.63]
RankingsWhere POLR1D stands among ~20K protein-coding genes
  • #5,689of 20,598
    Most Researched84
  • #2,238of 5,498
    Most Pathogenic Variants19
  • #15,789of 17,882
    Most Constrained (LOEUF)1.63
Genes detectedPOLR1D
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Treacher Collins Syndrome: Genetics, Clinical Features and Management.
PMID: 34573374
Genes (Basel) Β· 2021
1.00
2
Comprehensive genotype-phenotype analysis in POLR3-related disorders.
PMID: 40684265
HGG Adv Β· 2025
0.90
3
POLR1D, a shared subunit of RNA polymerase I and III, modulates mTORC1 activity.
PMID: 40222657
Biochim Biophys Acta Mol Cell Res Β· 2025
0.80
4
Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
PMID: 29364875
Nature Β· 2018
0.70
5
A clinically-relevant residue of POLR1D is required for Drosophila development.
PMID: 35656583
Dev Dyn Β· 2022
0.60